Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro

被引:5
作者
de Sa Brito Froes, Renata [1 ,2 ]
da Luz Moreira, Andre [3 ,4 ]
Carneiro, Antonio Jose de V. [5 ]
Moreira, Jessica P. L. [6 ]
Luiz, Ronir R. [6 ]
de Barros Moreira, Adriana Maria Hilu [2 ]
Monnerat, Camila Cesar [2 ]
de Souza, Heitor Siffert Pereira [4 ,5 ]
Carvalho, Ana Teresa Pugas [1 ]
机构
[1] Univ Estado Rio de Janeiro, Disciplina Gastroenterol & Endoscopia Digest, BR-20551900 Rio De Janeiro, RJ, Brazil
[2] Minist Econ, Pericia Med Fed PMF, Superintendencia Reg Subsecretaria PMF, BR-20030030 Rio De Janeiro, RJ, Brazil
[3] Univ Estado Rio de Janeiro, Disciplina Proctol, BR-20551900 Rio De Janeiro, RJ, Brazil
[4] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil
[5] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Dept Clin Med, Serv Gastroenterol,Ilha Fundao, Rua Prof Rodolpho Paulo Rocco 255, BR-21941913 Rio De Janeiro, RJ, Brazil
[6] Univ Fed Rio de Janeiro, Inst Estudos Saude Colet IESC, BR-21944970 Rio De Janeiro, Brazil
关键词
Inflammatory bowel disease; Crohn's disease; Work disability; Disease pension; Indirect costs; Productivity loss; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; BURDEN; ILLNESS; EPIDEMIOLOGY;
D O I
10.1007/s10620-020-06646-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Crohn's disease (CD) can lead to work disability with social and economic impacts worldwide. In Brazil, where its prevalence is increasing, we assessed the indirect costs, prevalence, and risk factors for work disability in the state of Rio de Janeiro and in a tertiary care referral center of the state. Methods Data were retrieved from the database of the Single System of Social Security Benefits Information, with a cross-check for aid pension and disability retirement. A subanalysis was performed with CD patients followed up at the tertiary care referral center using a prospective CD database, including clinical variables assessed as possible risk factors for work disability. Results From 2010 to 2018, the estimated prevalence of CD was 26.05 per 100,000 inhabitants, while the associated work disability was 16.6%, with indirect costs of US$ 8,562,195.86. Permanent disability occurred more frequently in those aged 40 to 49 years. In the referral center, the prevalence of work disability was 16.7%, with a mean interval of 3 years between diagnosis and the first benefit. Risk factors for absence from work were predominantly abdominal surgery, anovaginal fistulas, disease duration, and the A2 profile of the Montreal classification. Conclusions In Rio de Janeiro, work disability affects one-sixth of CD patients, and risk factors are associated with disease duration and complications. In the context of increasing prevalence, as this disability compromises young patients after a relatively short period of disease, the socioeconomic burden of CD is expected to increase in the future.
引用
收藏
页码:2925 / 2934
页数:10
相关论文
共 39 条
  • [1] Disability in Inflammatory Bowel Disease
    Abraham, Bincy P.
    Sellin, Joseph H.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 429 - +
  • [2] The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Alatab, Sudabeh
    Sepanlou, Sadaf G.
    Ikuta, Kevin
    Vahedi, Homayoon
    Bisignano, Catherine
    Safiri, Saeid
    Sadeghi, Anahita
    Nixon, Molly R.
    Abdoli, Amir
    Abolhassani, Hassan
    Alipour, Vahid
    Almadi, Majid A. H.
    Almasi-Hashiani, Amir
    Anushiravani, Amir
    Arabloo, Jalal
    Atique, Suleman
    Awasthi, Ashish
    Badawi, Alaa
    Baig, Atif A. A.
    Bhala, Neeraj
    Bijani, Ali
    Biondi, Antonio
    Borzi, Antonio M.
    Burke, Kristin E.
    Carvalho, Felix
    Daryani, Ahmad
    Dubey, Manisha
    Eftekhari, Aziz
    Fernandes, Eduarda
    Fernandes, Joao C.
    Fischer, Florian
    Haj-Mirzaian, Arvin
    Haj-Mirzaian, Arya
    Hasanzadeh, Amir
    Hashemian, Maryam
    Hay, Simon, I
    Hoang, Chi L.
    Househ, Mowafa
    Ilesanmi, Olayinka S.
    Balalami, Nader Jafari
    James, Spencer L.
    Kengne, Andre P.
    Malekzadeh, Masoud M.
    Merat, Shahin
    Meretoja, Tuomo J.
    Mestrovic, Tomislav
    Mirrakhimov, Erkin M.
    Mirzaei, Hamed
    Mohammad, Karzan A.
    Mokdad, Ali H.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 17 - 30
  • [3] Epidemiology and risk factors for IBD
    Ananthakrishnan, Ashwin N.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (04) : 205 - 217
  • [4] Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study
    Bassi, A
    Dodd, S
    Williamson, P
    Bodger, K
    [J]. GUT, 2004, 53 (10) : 1471 - 1478
  • [5] PROGNOSIS IN CROHNS-DISEASE - BASED ON RESULTS FROM A REGIONAL PATIENT GROUP FROM THE COUNTY OF COPENHAGEN
    BINDER, V
    HENDRIKSEN, C
    KREINER, S
    [J]. GUT, 1985, 26 (02) : 146 - 150
  • [6] The burden of inflammatory bowel disease in Europe
    Burisch, Johan
    Jess, Tine
    Martinato, Matteo
    Lakatos, Peter L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) : 322 - 337
  • [7] Adalimumab Induces Deep Remission in Patients With Crohn's Disease
    Colombel, Jean-Frederic
    Rutgeerts, Paul J.
    Sandborn, William J.
    Yang, Mei
    Camez, Anne
    Pollack, Paul F.
    Thakkar, Roopal B.
    Robinson, Anne M.
    Chen, Naijun
    Mulani, Parvez M.
    Chao, Jingdong
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (03) : 414 - +
  • [8] Employment status, difficulties at work and quality of life in inflammatory bowel disease patients
    De Boer, Angela G. E. M.
    Evertsz', Floor Bennebroek
    Stokkers, Pieter C.
    Bockting, Claudia L.
    Sanderman, Robert
    Hommes, Daniel W.
    Sprangers, Mirjam A. G.
    Frings-Dresen, Monique H. W.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (10) : 1130 - 1136
  • [9] de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2015.186, 10.1038/nrgastro.2016.186]
  • [10] Feagan BG, 2000, AM J GASTROENTEROL, V95, P1955